News for hackers. Stuff that matters.

A comment on Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval. Parent comment

Re:Third member of U.S. FDA advisory panel resigns over Alzh... by curtis3389 on Friday June 11, 2021 @09:41AM (#27473179)
It seems that the committee is an panel of outside advisors for the FDA.

The advisors advised that Aduhelm should not be approved because it only helps with a likely contributor to Alzheimer's, and it doesn't actually help with Alzheimer's.

The FDA ignored the panel and approved the drug anyways.

I wonder about the financial incentives and the corruption in the FDA. Every drug maker wants to be the first with an approved Alzheimer's drug; there's a ton of money to be made there.

[ Parent | on HN ]
Re:Third member of U.S. FDA advisory panel resigns over Alzh... by jhayward on Friday June 11, 2021 @04:47PM (#27478265)
> helps with a likely contributor to Alzheimer's

There is no evidence, and plenty of failed trials, to indicate that Amyloid plaque is a cause of Alzheimers.

[ Parent | on HN ]